health partners glp 1 coverage Massachusetts cuts GLP-1 for 460K public workers and retirees, jeopardizing obesity care and risking higher long-term costs. Learn more The GLP-1 Access Gap: Mapping

Among these, nausea mostly disappears after a few weeks of administration, and can be minimized by starting with a low dose and gradually increasing the dose

Standard Clinical Criteria for Prescription: A BMI of 30 or higher: This is classified as obesity and is the primary threshold for most weight-loss-specific GLP-1 medications

The Medullary Thyroid Cancer (MTC) Warning If you look at the patient information leaflet for GLP-1 medications, you will find a "black box" warning regarding thyroid C-cell tumours

adults are now taking GLP-1 medications, primarily for weight management

First clinical trial to investigate the efficacy and safety of combined SGLT2 inhibitor and GLP-1R agonist therapy in patients with T2DM, suggesting additive or synergistic effects on weight loss